Chuck Ence is CA and CO of RELMADA THERAPEUTICS, INC.. Currently has a direct ownership of 267,931 shares of RLMD, which is worth approximately $192,910. The most recent transaction as insider was on May 16, 2025, when has been sold 228,961 shares (Common Stock) at a price of $0.45 per share, resulting in proceeds of $103,032. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 268K
587.53% 3M change
587.53% 12M change
Total Value Held $192,910

Chuck Ence Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2025
BUY
Open market or private purchase
$103,032 $0.45 p/Share
228,961 Added 46.08%
267,931 Common Stock
Jan 31 2024
BUY
Open market or private purchase
$55,363 $4.05 p/Share
13,670 Added 25.97%
38,970 Common Stock
Jan 30 2024
BUY
Open market or private purchase
$56,115 $3.87 p/Share
14,500 Added 36.43%
25,300 Common Stock
Jan 29 2024
BUY
Open market or private purchase
$39,420 $3.65 p/Share
10,800 Added 50.0%
10,800 Common Stock
CE

Chuck Ence

CA and CO
New York, NY

Track Institutional and Insider Activities on RLMD

Follow RELMADA THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RLMD shares.

Notify only if

Insider Trading

Get notified when an Relmada Therapeutics, Inc. insider buys or sells RLMD shares.

Notify only if

News

Receive news related to RELMADA THERAPEUTICS, INC.

Track Activities on RLMD